Genetically-informed treatment for advanced and metastatic prostate cancer.
Genetically-informed treatment for advanced and metastatic prostate cancer.
Can J Urol. 2019 Oct;26(5S2):54-56
Authors: Morgans AK, Szymaniak BM
Abstract
The landscape of genetic testing for prostate cancer is rapidly evolving. There is increasing evidence that individuals with germline mutations in DNA-repair genes are more responsive to targeted therapies. Due to potential implications for treatment, these genes should be taken into consideration when determining the scope of genetic testing.
PMID: 31629435 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | Prostate Cancer | Urology & Nephrology